Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 7.37M P/E - EPS this Y - Ern Qtrly Grth -
Income -19.52M Forward P/E -0.34 EPS next Y - 50D Avg Chg 8.00%
Sales 7.47k PEG - EPS past 5Y - 200D Avg Chg -41.00%
Dividend N/A Price/Book 0.85 EPS next 5Y - 52W High Chg -85.00%
Recommedations 2.00 Quick Ratio 0.98 Shares Outstanding 8.66M 52W Low Chg 40.00%
Insider Own 12.02% ROA -219.89% Shares Float 4.72M Beta 0.48
Inst Own 14.01% ROE -454.72% Shares Shorted/Prior 174.44K/701.41K Price 3.64
Gross Margin - Profit Margin - Avg. Volume 11,241 Target Price -
Oper. Margin -263,285.18% Earnings Date Nov 7 Volume 8,775 Change -3.70%
About Oragenics Inc.

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Product Candidate, such as Mutacin 1140 (MU1140), a molecule belonging to the novel class of antibiotics. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

Oragenics Inc. News
10/18/24 Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit
10/09/24 Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation
10/08/24 Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002
10/08/24 EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate
09/05/24 Oragenics, Inc. Announces Closing of Public Offering
09/04/24 Oragenics, Inc. Announces Pricing of Public Offering
07:45 AM Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients
08/16/24 Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards
08/14/24 Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range
08/12/24 Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study
08/09/24 Oragenics: Q2 Earnings Snapshot
08/08/24 Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing
08/08/24 EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase II Trials Underway
07/10/24 Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients
06/27/24 Oragenics Develops Automated Intranasal Device for Treating Concussed Patients
06/24/24 Oragenics, Inc. Announces Proposed Public Offering
06/20/24 Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance
05/22/24 Oragenics Appoints William “Frank” Peacock MD as Chief Clinical Officer
05/17/24 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine
05/16/24 Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial
OGEN Chatroom

User Image NMax Posted - 21 minutes from now

$OGEN i.wonder if farve bought back in once they switched over from prevacus to Odyssey.

User Image NMax Posted - 1 hour ago

$OGEN Long and strong and eager to add! 🤑🤑🤑

User Image Chillywilly_72 Posted - 2 hours ago

$OGEN Certaibly have diluted some. But it's not much, tbh. It also seems we we may be getting ready for a spike. I see MM communications for shares and I have seen some 900's which means news coming.. As to why the others are asking for shares. Hopefully, we get it. It could be manipulation as well.

User Image SXCross Posted - 2 hours ago

$OGEN it doesn't look good. these scammers...

User Image RocketQueen Posted - 3 hours ago

$OGEN mentioned 90.00 USD before, but realistically my goal is to get something near the split price which was in the 8.00 to 10.00USD range in early 2023. I think that's possible with success in phase II. It has been a while since they'd had any updates, so would like to see something soon.

User Image Dh15708 Posted - 3 hours ago

$OGEN Whatever they do I'm going to keep adding.

User Image Dh15708 Posted - 3 hours ago

$OGEN I wouldn't be surprised if they give us some little news to raise the price and do another offering afterwards.

User Image Spilly0713 Posted - 4 hours ago

$OGEN I just want $5 a share, is that too much to ask????

User Image GTDFLY Posted - 4 hours ago

$OGEN praying for that phase 2 start before Xmas! 🤞👀

User Image SXCross Posted - 5 hours ago

$OGEN you can buy tens of thousands of shares every day. there are more than enough of them. Nobody knows how many more will be issued and whether the price will continue to fall. I'm waiting for 20 cents or lower to discount.

User Image HumanityFirst Posted - 6 hours ago

$OGEN the race is on to buy as many shares as possible at these prices! Bring it on!

User Image NMax Posted - 21 hours ago

$OGEN Oragenics management has not fought to bring value to their asset and has allowed ATL after ATL for several years now. They provide no real substance with their project updates and have repeatedly misled investors on their project timelines regarding filing INDs and beginning clinicals. Given all this its pretty rediculous and probably irresponsible to send your (interim ceo) michael redmond to the bahamas for a presentation, while continually keeping retail investors in the dark. Heres just some of the things retail payed for Michael Redmond to enjoy:

User Image Alani_Jefferson Posted - 1 day ago

$OGEN

User Image NMax Posted - 1 day ago

$OGEN time to double my position 🤑🤑🤑 👋

User Image RocketQueen Posted - 1 day ago

$OGEN if they could get RFKJR on board this would rocket. Unlike my other stocks going to the moon, this is still being it's usual self. Honestly, all circumstances considered this is grossly under priced and under valued. It will be interesting to see what Koski decides to do this year.

User Image HumanityFirst Posted - 1 day ago

$OGEN adding through December. JFKR might actually favor a nasal approach to vaccine over injection.

User Image CounterIntuitive Posted - 1 day ago

$OGEN Going down again... they don't produce anything but random news. Don't get sucked into this company.

User Image Rbottom1 Posted - 2 days ago

$OGEN it's hammer time!

User Image Gunflint Posted - 2 days ago

$OGEN don’t know what kind of event we need for this project to skyrocket… still hoping for that to happen

User Image NMax Posted - 2 days ago

$OGEN about as much volume this year as the last 6 years combined. More volume just in Friday's after hours then all of 2022 or 2023 Safe to say something huge is coming.

User Image NMax Posted - 2 days ago

$OGEN adding!

User Image SXCross Posted - 2 days ago

$OGEN or is there news today?

User Image MiddleAmerica Posted - 2 days ago

$OGEN wonder if we can hit a penny.

User Image SXCross Posted - 2 days ago

$OGEN crash

User Image SXCross Posted - 2 days ago

$OGEN I'm waiting for 20 cents.

User Image Spilly0713 Posted - 2 days ago

$OGEN staring phase 2 between now and end of year. Good luck timing it👌 I’ll continue to add. ESPECIALLY under .30

User Image NMax Posted - 3 days ago

$OGEN It kind of appears like Oragenics is fulfilling short contracts through dilution since they can't get retail to sell. You can see options contracts movements proceeding company dilution with no news.

User Image RocketQueen Posted - 3 days ago

$OGEN the NYSE MKT accepted their compliance plan, but what is the next action or time period needed to retain listing status?

User Image RocketQueen Posted - 3 days ago

$OGEN followup from previous post with information directly from Oragenics webiste: "A Phase II clinical trial is anticipated to be performed administering ONP-002 intranasally to concussed patients 2x a day for 10 days. The Phase IIa feasibility study is anticipated to be performed in AUS with a target initiation date in the 4th quarter of 2024 to be followed closely by a Phase IIb proof of concept study in the US following IND approval in the 1 st quarter of 2025".

User Image Jimmymalik123 Posted - 3 days ago

$OGEN even if they announce and bounce it will go up 200% and that takes us to 0.6/0.7 bloody hell everyone is 4+! Or even worse

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Telling Fred Director Director Nov 30 Sell 3.5681 3,500 12,488 38,345 12/01/23
Telling Fred Director Director Jun 17 Buy .2860 10,084 2,884 1,010,000 06/21/22
Sullivan Michael O'Keefe Interim PEO, CFO Interim PEO, CFO Mar 29 Buy .3461 20,000 6,922 34,255 03/30/22